Publication at Faculty of Medicine in Hradec Králové |
2020
Abstract
Lurasidone is an antipsychotic agent newly available in the Czech Republic. It belongs among the serotonin-dopamine antagonist group of antipsychotics.
It is indicated for the treatment of schizophrenia. The case report described below illustrates the treatment of the symptoms of psychosis with lurasidone and shows the solution of some side effects.